X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (73) 73
Book Review (12) 12
Book / eBook (10) 10
Patent (10) 10
Conference Proceeding (4) 4
Publication (4) 4
Book Chapter (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (50) 50
humans (46) 46
male (33) 33
oncology (30) 30
middle aged (26) 26
female (25) 25
aged (23) 23
adult (21) 21
cancer (15) 15
chemotherapy (14) 14
mutation (13) 13
aged, 80 and over (12) 12
cetuximab (12) 12
colorectal cancer (12) 12
prognosis (12) 12
chemistry (11) 11
microbiology (11) 11
treatment outcome (11) 11
analysis (10) 10
antineoplastic agents - therapeutic use (10) 10
beer (10) 10
biochemistry (10) 10
compositions or test papers therefor (10) 10
condition-responsive control in microbiological orenzymological processes (10) 10
enzymology (10) 10
human necessities (10) 10
hygiene (10) 10
investigating or analysing materials by determining theirchemical or physical properties (10) 10
measuring (10) 10
measuring or testing processes involving enzymes, nucleicacids or microorganisms (10) 10
medical or veterinary science (10) 10
metallurgy (10) 10
mutation or genetic engineering (10) 10
organic chemistry (10) 10
peptides (10) 10
physics (10) 10
preparations for medical, dental, or toilet purposes (10) 10
processes of preparing such compositions (10) 10
specific therapeutic activity of chemical compounds ormedicinal preparations (10) 10
spirits (10) 10
testing (10) 10
vinegar (10) 10
wine (10) 10
colorectal neoplasms - drug therapy (9) 9
colorectal neoplasms - genetics (9) 9
genetic aspects (9) 9
metastasis (9) 9
antibodies, monoclonal, humanized (8) 8
colorectal neoplasms - pathology (8) 8
neoplasm metastasis (8) 8
neuroendocrine tumors (8) 8
retrospective studies (8) 8
tumors (8) 8
animals (7) 7
neoplasm staging (7) 7
neuroendocrine tumors - pathology (7) 7
antibodies, monoclonal - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
braf (6) 6
class i phosphatidylinositol 3-kinases (6) 6
disease-free survival (6) 6
egfr (6) 6
neoplasms (6) 6
phase-ii (6) 6
proteins (6) 6
proto-oncogene proteins b-raf - genetics (6) 6
receptor, epidermal growth factor - antagonists & inhibitors (6) 6
survival rate (6) 6
adenocarcinoma - drug therapy (5) 5
biomarkers (5) 5
cancer research (5) 5
care and treatment (5) 5
development and progression (5) 5
genes, ras (5) 5
growth (5) 5
lung neoplasms - drug therapy (5) 5
phosphatidylinositol 3-kinases - genetics (5) 5
proto-oncogene proteins p21 (5) 5
research article (5) 5
survival analysis (5) 5
antimitotic agents (4) 4
antineoplastic agents (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - pharmacology (4) 4
apoptosis (4) 4
carcinoma (4) 4
clinical study (4) 4
colon-cancer (4) 4
deoxyribonucleic acid--dna (4) 4
disease progression (4) 4
dna (4) 4
gene expression regulation, neoplastic (4) 4
growth-factor-receptor (4) 4
k-ras (4) 4
k-ras mutations (4) 4
kras (4) 4
lung neoplasms - pathology (4) 4
lymphatic metastasis (4) 4
medical research (4) 4
medicine (4) 4
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (87) 87
Italian (10) 10
French (5) 5
Chinese (1) 1
German (1) 1
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2008, Volume 26, Issue 35, pp. 5705 - 5712
Purpose Cetuximab or panitumumab are effective in 10% to 20% unselected metastatic colorectal cancer (CRC) patients. KRAS mutations account for approximately... 
GROWTH-FACTOR RECEPTOR | PHASE-II TRIAL | PROGNOSTIC-FACTOR | MUTATION STATUS | THERAPY | ONCOLOGY | MISMATCH-REPAIR | OPEN-LABEL | KRAS | GENE COPY NUMBER | CHEMOTHERAPY | Niacinamide - analogs & derivatives | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Phenylurea Compounds | Patient Selection | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Benzenesulfonates - pharmacology | Neoplasm Metastasis | Time Factors | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Cetuximab | Cell Survival - drug effects | Colorectal Neoplasms - enzymology | Proto-Oncogene Proteins - genetics | Treatment Outcome | Switzerland | HT29 Cells | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Proto-Oncogene Proteins B-raf - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Italy | Aged | Biomarkers, Tumor - genetics | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Mutation | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 8, pp. 753 - 762
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2009, Volume 4, Issue 10, pp. e7287 - e7287
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2011, Volume 17, Issue 14, pp. 4901 - 4914
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2007, Volume 59, Issue 5, pp. 637 - 642
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2013, Volume 72, Issue 1, pp. 159 - 165
Adjuvant chemotherapy is gaining an increasing role in resectable gastric cancer. Customizing chemotherapy on the basis of chemosensitivity may improve... 
Medicine & Public Health | ERCC1 | Oncology | Cancer Research | Gastric | Adjuvant | Pharmacology/Toxicology | Cisplatin | GASTROESOPHAGEAL CANCER | RANDOMIZED-TRIALS | THYMIDYLATE SYNTHASE | CURATIVE RESECTION | DRUG-RESISTANCE | 5-FLUOROURACIL-BASED SYSTEMIC CHEMOTHERAPY | GROWTH-FACTOR RECEPTOR | LUNG-CANCER | ONCOLOGY | PHARMACOLOGY & PHARMACY | EXPRESSION | THYMIDINE PHOSPHORYLASE | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Stomach Neoplasms - metabolism | Male | Stomach Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Stomach - metabolism | Antineoplastic Agents - administration & dosage | Endonucleases - metabolism | Neoplasm Proteins - metabolism | Stomach - surgery | Cisplatin - administration & dosage | DNA-Binding Proteins - metabolism | Adenocarcinoma - metabolism | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Stomach - drug effects | Stomach - pathology | Europe | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Cisplatin - therapeutic use | Survival Analysis | Aged | Neoplasm Staging | Stomach Neoplasms - surgery | Adenocarcinoma - surgery | Cohort Studies | Immunohistochemistry | Medical research | Prognosis | Patient outcomes | Antineoplastic agents | Stomach cancer | Antimitotic agents | Cancer patients | Chemotherapy | Analysis | Medicine, Experimental | Tumor proteins | Cancer | Index Medicus
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. 2515 - 2515
Conference Proceeding